4 completed, 3 unknown, 1 suspended, 1 terminated. 9 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 4, Unknown 3, Suspended 1, Terminated 1 |
| Phase 2 | 5 | Completed 2, Unknown 2, Terminated 1 |
Follow Sprim Advanced Life Sciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multistrain Probiotic for Functional Constipation High dose Multistrain probiotic, 100 billion cfu/day, Low dose Multistrain probiotic, 15 billion cfu/day - Functional Constipation | Phase 2 / Phase 3 | Unknown | Renew Life Formulas Inc | 81 | 2012-06-01 | 2012-11-30 |
| Trenev Trio®/Healthy Trinity® for Recurrent Gastrointestinal Symptoms Trenev Trio®/Healthy Trinity®, Placebo - Recurrent Gastrointestinal Symptoms | Phase 2 / Phase 3 | Unknown | Sprim Advanced Life Sciences | 120 | 2012-02-01 | 2012-10-24 |
| Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia Probiotic, Placebo - IBS-D and Functional Dyspepsia | Phase 2 / Phase 3 | Terminated | Sprim Advanced Life Sciences | 120 | 2011-01-01 | 2011-07-21 |
| Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults Bifidobacterium lactis HN019, Placebo - Influenza | Phase 3 | Unknown | Fonterra Research Centre | 426 | 2010-12-01 | 2010-12-13 |
| Evaluation of the Efficacy and Tolerability of ABO/MEG-B-09 in Children With Acute Cough AboMeg-B-09, Placebo - Cough | Phase 3 | Completed | Aboca Spa Societa' Agricola | 102 | 2010-10-01 | 2014-12-02 |
| BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection Lactobacillus acidophilus CL1285® and Lactobacillus casei, Placebo - Recurrent Clostridium Difficile Infection | Phase 3 | Suspended | Bio-K Plus International Inc. | 140 | 2010-06-01 | 2016-01-15 |
| Effect of Bifidobacterium Lactis HN019 on Colonic Transit Time and Digestive Symptoms Bifidobacterium lactis HN019, Placebo - Gastrointestinal Symptoms | Phase 2 / Phase 3 | Completed | Fonterra Research Centre | 100 | 2009-06-01 | 2010-07-28 |
| Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection BIO-K+ CL-1285®, Placebo - Antibiotic-Associated Diarrhea, Clostridium Difficile-Associated Diarrhea | Phase 3 | Completed | Bio-K Plus International Inc. | 255 | 2008-12-01 | 2012-03-13 |
| Effects of NUTRIOSE®FB Dietary Fiber Supplementation on Satiety, Body Fat, and Metabolic Syndrome in Overweight Adult Men NUTRIOSE, Placebo - Overweight, Metabolic Syndrome X | Phase 2 / Phase 3 | Completed | Roquette Freres | 120 | 2006-10-01 | 2010-01-08 |
Diarrhea (2) · Clostridium Infections (1) · Constipation (1) · Cough (1) · Dyspepsia (1) · Influenza, Human (1) · Metabolic Syndrome (1) · Overweight (1)
Probiotics (2) · Exercise (1) · NUTRIOSE (1)
United States (5) · China (1) · Italy (1)
Duane Wombolt, MD (2) · JoAnn Hattner, MPH, RD (2) · Arienne de Jong, PhD (1) · Cornelius J Foley, MD (1) · David Wyatt, MD (1) · Emilio Clementi (1) · Gao XingWang, MD (1) · Helen Stacey, MD (1) · Jeffrey Stewart, MD (1) · Lydie Hazan, MD (1) · Mario Clerici, MD (1) · Michael Sinitsa, MD (1) · Philip Waller, MD (1) · Shuguang Li, MD (1)